NCT06755684
- Conditions
- Antineoplastic Agents, Bevacizumab, Bronchial Neoplasms, +15 more
- Locations
-
- Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.
NCT06755684
NCT06756217
NCT06749691
NCT06745830
NCT06403111
NCT06281678
NCT06056999
NCT06705465
NCT06737107
NCT06734182